Phibro Animal Health (NASDAQ:PAHC) Shares Down 6.1% – Here’s What Happened
by Amy Steele · The Cerbat GemPhibro Animal Health Corporation (NASDAQ:PAHC – Get Free Report) traded down 6.1% during trading on Monday . The company traded as low as $37.62 and last traded at $37.55. 120,852 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 293,232 shares. The stock had previously closed at $40.00.
Analysts Set New Price Targets
Several equities research analysts recently commented on the company. Weiss Ratings lowered Phibro Animal Health from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday. Citigroup assumed coverage on Phibro Animal Health in a research report on Wednesday, April 15th. They set a “neutral” rating and a $62.00 target price on the stock. Wall Street Zen lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 11th. Finally, Morgan Stanley set a $49.00 target price on Phibro Animal Health in a research report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $42.40.
View Our Latest Report on PAHC
Phibro Animal Health Trading Down 3.6%
The company has a current ratio of 3.17, a quick ratio of 1.26 and a debt-to-equity ratio of 1.97. The firm has a 50-day moving average of $52.91 and a 200 day moving average of $46.44. The company has a market cap of $1.43 billion, a P/E ratio of 15.13, a price-to-earnings-growth ratio of 0.55 and a beta of 0.61.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. Phibro Animal Health had a return on equity of 37.14% and a net margin of 6.35%.The business had revenue of $383.54 million for the quarter, compared to the consensus estimate of $367.02 million. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. On average, analysts predict that Phibro Animal Health Corporation will post 3.06 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 24th. Investors of record on Wednesday, June 3rd will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Wednesday, June 3rd. Phibro Animal Health’s dividend payout ratio is 20.60%.
Insiders Place Their Bets
In related news, CEO Jack Bendheim sold 10,560 shares of the company’s stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $52.68, for a total transaction of $556,300.80. Following the transaction, the chief executive officer directly owned 80,360 shares of the company’s stock, valued at approximately $4,233,364.80. This represents a 11.61% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last 90 days, insiders sold 110,128 shares of company stock worth $5,846,828. 50.13% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. 1620 Investment Advisors Inc. raised its stake in Phibro Animal Health by 77.4% during the 4th quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company’s stock worth $25,000 after buying an additional 295 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Phibro Animal Health by 113.2% in the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock worth $27,000 after purchasing an additional 386 shares during the last quarter. KBC Group NV purchased a new stake in shares of Phibro Animal Health in the first quarter worth approximately $29,000. Rothschild Investment LLC raised its stake in shares of Phibro Animal Health by 2,500.0% in the fourth quarter. Rothschild Investment LLC now owns 1,040 shares of the company’s stock worth $39,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Hughes Financial Services LLC purchased a new stake in shares of Phibro Animal Health in the third quarter worth approximately $40,000. 99.34% of the stock is owned by institutional investors and hedge funds.
About Phibro Animal Health
Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.
The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.